Response to Interleukin-1 Blockade With Anakinra in Black and White Americans With ST-Segment Elevation Myocardial Infarction.
作者信息
Corna Giuliana, Golino Michele, Moroni Francesco, Del Buono Marco Giuseppe, Talasaz Azita H, Decotto Santiago, Mbualungu James, Trankle Cory R, Thomas Georgia K, Markley Roshanak, Canada Justin M, Turlington Jeremy, Agatiello Carla R, Keen Larry, Van Tassell Benjamin, Abbate Antonio
机构信息
VCU Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia; Interventional Cardiology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
VCU Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia; Department of Medicine and Surgery, University of Insubria, Varese, Italy.
出版信息
Am J Cardiol. 2023 Nov 15;207:336-338. doi: 10.1016/j.amjcard.2023.08.175. Epub 2023 Sep 27.
Abstract
摘要
相似文献
1
Response to Interleukin-1 Blockade With Anakinra in Black and White Americans With ST-Segment Elevation Myocardial Infarction.阿那白滞素对白种人和黑种人ST段抬高型心肌梗死患者白细胞介素-1阻断的反应
Am J Cardiol. 2023 Nov 15;207:336-338. doi: 10.1016/j.amjcard.2023.08.175. Epub 2023 Sep 27.
2
Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.白细胞介素-1 阻断剂抑制 ST 段抬高型心肌梗死患者的急性炎症反应。
J Am Heart Assoc. 2020 Mar 3;9(5):e014941. doi: 10.1161/JAHA.119.014941.
3
Response to interleukin-1 blockade with anakinra in women and men with ST-segment elevation myocardial infarction.在患有ST段抬高型心肌梗死的男性和女性中使用阿那白滞素对白介素-1进行阻断的反应。
Minerva Cardiol Angiol. 2024 Feb;72(1):67-75. doi: 10.23736/S2724-5683.23.06439-6. Epub 2023 Nov 21.
4
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials.阿那白滞素阻断白细胞介素-1 与 ST 段抬高型心肌梗死后的心力衰竭：VCUART 临床试验的汇总分析结果。
Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):503-510. doi: 10.1093/ehjcvp/pvab075.
5
Clinical and Pharmacological Implications of Time to Treatment with Interleukin-1 Blockade in ST-Segment Elevation Myocardial Infarction.ST 段抬高型心肌梗死中白细胞介素-1 阻断治疗时间的临床和药理学意义。
J Pharmacol Exp Ther. 2023 Aug;386(2):156-163. doi: 10.1124/jpet.123.001601. Epub 2023 Apr 10.
6
Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction.C-反应蛋白水平的影响及阿那白滞素在 ST 段抬高型心肌梗死患者中的作用。
Int J Cardiol. 2024 Mar 1;398:131610. doi: 10.1016/j.ijcard.2023.131610. Epub 2023 Nov 26.
7
Role of anakinra in patients with ST-elevation myocardial infarction.
Int J Cardiol. 2024 Sep 15;411:132297. doi: 10.1016/j.ijcard.2024.132297. Epub 2024 Jun 25.
8
Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study].阿那白滞素阻断白细胞介素-1对急性心肌梗死后不良心脏重构和心力衰竭的影响 [来自弗吉尼亚联邦大学-阿那白滞素重构试验 (2) (VCU-ART2) 试点研究]。
Am J Cardiol. 2013 May 15;111(10):1394-400. doi: 10.1016/j.amjcard.2013.01.287. Epub 2013 Feb 27.
9
Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction.阿那白滞素阻断白细胞介素-1对 ST 段抬高型急性心肌梗死患者白细胞计数的影响。
Sci Rep. 2022 Jan 24;12(1):1254. doi: 10.1038/s41598-022-05374-w.
10
Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study.弗吉尼亚联邦大学-阿那白滞素重塑试验-3（VCU-ART3）的原理与设计：一项随机、安慰剂对照、双盲、多中心研究。
Clin Cardiol. 2018 Aug;41(8):1004-1008. doi: 10.1002/clc.22988. Epub 2018 Aug 17.
引用本文的文献
1
Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment Elevation Myocardial Infarction: Secondary End Points From an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study.RPH-104（戈弗利西普）对ST段抬高型心肌梗死患者进行白细胞介素-1阻断治疗：一项国际、双盲、随机、安慰剂对照的2a期研究的次要终点
J Cardiovasc Pharmacol. 2024 Dec 1;84(6):565-577. doi: 10.1097/FJC.0000000000001635.
2
Recent Advances in Targeted Management of Inflammation In Atherosclerosis: A Narrative Review.动脉粥样硬化炎症靶向管理的最新进展：叙述性综述
Cardiol Ther. 2024 Sep;13(3):465-491. doi: 10.1007/s40119-024-00376-3. Epub 2024 Jul 20.
本文引用的文献
1
Race-Based Differences in ST-Segment-Elevation Myocardial Infarction Process Metrics and Mortality From 2015 Through 2021: An Analysis of 178 062 Patients From the American Heart Association Get With The Guidelines-Coronary Artery Disease Registry.种族差异对 ST 段抬高型心肌梗死处理指标和死亡率的影响：2015 年至 2021 年美国心脏协会 Get With The Guidelines-Coronary Artery Disease 注册研究 178062 例患者分析。
Circulation. 2023 Jul 18;148(3):229-240. doi: 10.1161/CIRCULATIONAHA.123.065512. Epub 2023 Jul 17.
2
Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction.缺血性心肌病和急性心肌梗死后心力衰竭。
Curr Cardiol Rep. 2022 Oct;24(10):1505-1515. doi: 10.1007/s11886-022-01766-6. Epub 2022 Aug 16.
3
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials.阿那白滞素阻断白细胞介素-1 与 ST 段抬高型心肌梗死后的心力衰竭：VCUART 临床试验的汇总分析结果。
Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):503-510. doi: 10.1093/ehjcvp/pvab075.
4
Cardiovascular Disease Events and Mortality After Myocardial Infarction Among Black and White Adults: REGARDS Study.心肌梗死后黑人和白人成年人的心血管疾病事件和死亡率：REGARDS 研究。
Circ Cardiovasc Qual Outcomes. 2020 Dec;13(12):e006683. doi: 10.1161/CIRCOUTCOMES.120.006683. Epub 2020 Dec 11.
5
Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.白细胞介素-1 阻断剂抑制 ST 段抬高型心肌梗死患者的急性炎症反应。
J Am Heart Assoc. 2020 Mar 3;9(5):e014941. doi: 10.1161/JAHA.119.014941.
6
Racial and Ethnic Differences in Acute Coronary Syndrome and Myocardial Infarction Within the United States: From Demographics to Outcomes.美国急性冠状动脉综合征和心肌梗死的种族和族裔差异：从人口统计学特征到治疗结果
Clin Cardiol. 2016 May;39(5):299-306. doi: 10.1002/clc.22524. Epub 2016 Mar 30.
7
Inflammatory markers in ST-elevation acute myocardial infarction.ST段抬高型急性心肌梗死中的炎症标志物
Eur Heart J Acute Cardiovasc Care. 2016 Aug;5(4):382-95. doi: 10.1177/2048872615568965. Epub 2015 Feb 13.
8
Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study].阿那白滞素阻断白细胞介素-1对急性心肌梗死后不良心脏重构和心力衰竭的影响 [来自弗吉尼亚联邦大学-阿那白滞素重构试验 (2) (VCU-ART2) 试点研究]。
Am J Cardiol. 2013 May 15;111(10):1394-400. doi: 10.1016/j.amjcard.2013.01.287. Epub 2013 Feb 27.
9
Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).白细胞介素-1 阻断剂阿那白滞素预防急性心肌梗死后不良心脏重构（弗吉尼亚联邦大学阿那白滞素重构试验[VCU-ART] 初步研究）。
Am J Cardiol. 2010 May 15;105(10):1371-1377.e1. doi: 10.1016/j.amjcard.2009.12.059. Epub 2010 Apr 2.
Zotero 插件